semaglutide vs insulin Efficacy and safety of once-weekly versus once-daily glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre Oral Semaglutide Shows Promise in
Description
Individual variation is significantsome patients feel profound appetite suppression immediately, while others experience gradual changes over weeks
If successful, future work investigating the combination of an SGLT2i with a dual continuous glucose and ketone sensor may allow individuals with type 1 diabetes to access SGLT2i therapy
Cochrane Database Syst Rev 2014;(4):CD007004
So how does this small subset of people online, this niche, become much more mainstream
Hiromine Y, Noso S, Rakugi H, Sugimoto K, Takata Y, Katsuya T, et al
JCI INSIGHT
